News Updates

Praxsyn Corporate Update

Corporate Developments and Future Plans

SCOTTSDALE, Arizona — February 4, 2022 ( — Praxsyn Corporation’s (OTC: PXYN, the “Company”) subsidiary, Mesa Pharmacy, Inc., through its attorneys, had filed a Petition for Reconsideration of the Findings of Fact and Opinion on Decision regarding its pending litigation in California before the Workers’ Compensation Appeals Board.  The Workers’ Compensation Appeals Board of the State of California has issued an Opinion and Order Granting Petition For Reconsideration for the purpose of further deciding the substantive issues in the case.  The Company is still awaiting further updates on the Petition For Reconsideration from counsel and the Workers’ Compensation Appeals Board.

Since the last press release, the Company has been continuing to work on the missing filings to become current.  The disruptions to the expected timeline to complete the missing filings are beyond the control of the Company.  In conjunction with completing the missing filings, the Company intends to explore financing, business development, and restructuring opportunities as it awaits further updates on the Mesa Pharmacy receivables.  The Company will continue to update shareholders periodically.

About Praxsyn Corporation

Headquartered in Scottsdale, Arizona, Praxsyn Corporation works to realize the vision of medical professionals to improve the lives of their patients. Additional company information can be found at

Forward-Looking Statement This Press Release contains forward-looking statements that involve risks and uncertainties, which may include statements about business strategy and development plans, plans for entering a new business, anticipated sources of funds, including proceeds from future operations and plans, objectives, expectations, and intentions contained in the Press Release that are not historical facts such as “estimated gross”…prospective resources, total potential revenue, substantially exceeds, etc. “Because these forward-looking statements involve risk and uncertainties, actual results could differ materially from those discussed in this Press Release.

You can find official press release here:

Close Bitnami banner